Skip to content

Clinical trials

Phase 3 Immune System Diseases trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Immune System Diseases Phase: Phase 3 Country / region: Italy Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20121
20151
20161
20171
20182
20221
20232
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Active, not recruiting2
Recruiting2
Terminated2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
Pfizer2
Takeda2
Adienne SA1
Ariad Pharmaceuticals1
Baxalta now part of Shire1
Biogen1
Bristol-Myers Squibb1
Eli Lilly and Company1
La Jolla Pharmaceutical Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Immune System Diseases13
Autoimmune Diseases7
Lupus Erythematosus, Systemic4
Connective Tissue Diseases3
Hematologic Diseases3
Hypersensitivity3
Hypersensitivity, Immediate3
Blood Platelet Disorders2
Cytopenia2
Dermatitis2

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.